With a market cap of $80.3 billion, The Travelers Companies, Inc. (TRV) is a leading provider of commercial and personal property and casualty insurance, serving businesses, government entities, and individuals in the United States and internationally. It operates through three main segments: Business Insurance; Bond & Specialty Insurance; and Personal Insurance, offering a broad portfolio of risk and insurance solutions.
Shares of the New York-based company have surpassed the broader market over the past 52 weeks. TRV stock has soared 36.8% over this time frame, while the broader S&P 500 Index ($SPX) has returned 8%. Moreover, shares of the company are up 34.7% on a YTD basis, compared to SPX’s 4.8% rise.
More Top Stocks Daily: Go behind Wall Street’s hottest headlines with Barchart’s Active Investor newsletter.
Focusing more closely, shares of the insurer have outpaced the State Street Financial Select Sector SPDR ETF’s (XLF) 7.8% gain over the past 52 weeks.
Travelers shares rose 1.5% on Oct. 16, with better-than-expected Q3 2026 core EPS increasing 13% year-over-year to $9.18, driven by favorable prior-year reserve development and higher net investment income. Underwriting performance also strengthened, as the combined ratio improved to 86.8% and beat the analyst estimate, and net written premiums edged up to $11.48 billion. Despite a slight revenue decline to $12.41 billion and a 7% drop in Personal Insurance premiums to $4.40 billion, growth in Business Insurance premiums (up 3% to $5.87 billion) and Bond & Specialty Insurance (up 12% to $1.21 billion), alongside management's confidence heading into 2027, supported investor sentiment.
For the fiscal year ending in December 2026, analysts expect Travelers’ core EPS to increase 31.5% year-over-year to $36.27. The company’s earnings surprise history is promising. It beat the consensus estimates in each of the last four quarters.
Among the 31 analysts covering the stock, the consensus rating is a “Hold.” That’s based on seven “Strong Buy” ratings, 19 “Moderate Buy,” two “Moderate Sell,” and three “Strong Sells.”
This configuration is slightly less bullish than three months ago, with eight “Strong Buy” ratings on the stock.
On Oct. 26, Roth Capital analyst Harry Fong raised Travelers’ price target to $460, maintaining a “Buy” rating.
As of writing, the stock is trading above the mean price target of $385.42. The Street-high price target of $460 suggests a 17.8% potential upside.
On the date of publication, Sohini Mondal did not directly have a position in any of the securities mentioned in this article. All information and data in this article is solely for informational purposes. For more information please view the Barchart Disclosure Policy here.
More news from Barchart
Disney Just Boosted Its Dividend by 33%. That Gives DIS Stock Investors a Real Reason to Stick Around. The Worst Might Be Over for Somnigroup as Credit Metrics Improve HSBC Just Turned Bullish on Cisco Stock Again. Here’s Why It Expects 40% Upside. Paul Tudor Jones’ Initiates a New Position in This Profitable Midcap Tech Stock